You noticed new dark spots after a procedure, or maybe your provider's notes mention "hyperpigmentation" alongside a code you don't recognize. Either way, you're here because something changed with your skin and you want answers. Hyperpigmentation ICD 10 codes are the standardized classification system that providers use to document pigmentation-related skin concerns on your medical records, insurance claims, and referral paperwork. Whether you're dealing with post-procedure darkening, melasma that flared unexpectedly, or hyperpigmentation that appeared without a clear trigger, understanding what these codes mean - and what they don't mean - puts you back in control of your care journey.
This guide walks you through the full landscape of hyperpigmentation coding, connects it to real-world post-procedure scenarios like microneedling and chemical peels, and outlines what responsible aftercare looks like during recovery. We'll cover everything from broad unspecified codes to highly specific anatomical classifications, and we'll be transparent about where evidence is strong and where practical guidance is based on established clinical practice.
What Is Hyperpigmentation ICD 10
ICD-10 stands for the International Classification of Diseases, Tenth Revision. It's a globally standardized system used by healthcare providers, insurance companies, and researchers to categorize and document medical conditions. When your provider assigns a hyperpigmentation ICD-10 code to your visit, they're essentially creating a standardized label that communicates what was observed during your examination.
Here's what's important to understand: an ICD-10 code is not a severity rating. It's not a prognosis. It doesn't tell you whether your condition is temporary or permanent, and it doesn't prescribe a specific treatment. It's a documentation tool that enables three critical functions in your healthcare experience.
First, it allows insurance processing. Your insurer uses these codes to determine coverage eligibility for treatments, referrals, and follow-up visits. Second, it enables research tracking. When researchers want to study how many people experience drug-induced hyperpigmentation or melasma, they use ICD codes to identify those populations in large datasets. Research has specifically validated that ICD-based case identification can reliably capture hyperpigmentation cases in clinical databases (Theodosakis et al., 2022, JEADV). Third, it supports care coordination. When you're referred to a specialist or when your records transfer between providers, the ICD code communicates the documented concern quickly and universally.
The hyperpigmentation codes fall primarily under the L81 category in ICD-10-CM, which covers "Other disorders of pigmentation." Within this category, you'll find codes ranging from broad and unspecified to highly detailed classifications based on cause, location, and clinical presentation.
Hyperpigmentation ICD 10 Code
The primary ICD-10 code for hyperpigmentation is L81.4, which documents "Other melanin hyperpigmentation." However, hyperpigmentation isn't a single condition - it's an umbrella term covering dozens of distinct presentations with different causes, locations, and clinical implications. That's why the ICD-10 system offers multiple coding options rather than a single catch-all.
The most commonly encountered hyperpigmentation-related codes include:
→ L81.0 - Post-inflammatory hyperpigmentation
→ L81.1 - Chloasma (melasma)
→ L81.4 - Other melanin hyperpigmentation
→ L81.8 - Other specified disorders of pigmentation
→ L81.9 - Disorder of pigmentation, unspecified
Your provider selects the most appropriate code based on clinical presentation, suspected etiology, and the specificity of documentation available at the time of your visit. More specific coding generally supports better insurance outcomes and more accurate research data. Validation studies have confirmed that when providers code specifically - particularly for melasma and drug-induced hyperpigmentation - the codes reliably identify true cases (Theodosakis et al., 2022, JAMA Dermatol; Theodosakis et al., 2022, JEADV).
Hyperpigmentation ICD 10 CM Code
ICD-10-CM refers specifically to the Clinical Modification of ICD-10 used in the United States. While ICD-10 is the international standard maintained by the World Health Organization, the CM version adds additional specificity required for U.S. healthcare documentation, billing, and reimbursement.
For hyperpigmentation, the ICD-10-CM system provides the same L81 category structure but allows for greater granularity in documentation. This matters because U.S. insurance systems often require specific codes to authorize treatments like prescription lightening agents, laser therapy, or chemical peels for pigmentation concerns.
The key distinction for patients: if your paperwork shows an ICD-10-CM code, you're looking at U.S.-specific clinical documentation. The codes themselves function identically to the international classification for hyperpigmentation purposes, but the CM designation confirms your provider is using the American clinical modification standard required for domestic insurance processing.
When you see L81 followed by additional digits on your documentation, each additional character adds specificity. L81 alone indicates a pigmentation disorder. L81.4 specifies melanin-based hyperpigmentation. Further modifiers can indicate location, laterality, or associated conditions.
ICD 10 Code for Unspecified Hyperpigmentation
The code L81.9 represents "Disorder of pigmentation, unspecified." This is the broadest possible classification for hyperpigmentation and is used when your provider observes a pigmentation concern but cannot or has not yet determined the specific type, cause, or subclassification.
You might see this code on your records in several common scenarios:
→ Your initial visit where hyperpigmentation was noted but not fully evaluated
→ Time-limited appointments where detailed pigmentation assessment wasn't the primary focus
→ Cases where the trigger is genuinely unclear and requires further investigation
→ Telehealth visits where visual assessment is limited
Here's the practical implication: unspecified codes can sometimes complicate insurance pre-authorization for targeted treatments. If your insurer requires medical necessity documentation for a specific pigmentation treatment, a vague code may trigger a denial or request for additional information.
💡 Pro tip: At your follow-up visit, ask your provider: "Can you document the suspected cause of my hyperpigmentation in my chart?" Whether it started after a procedure, medication, pregnancy, or sun exposure, that specificity helps your coding become more precise - which supports better insurance outcomes and contributes to more accurate research data. Research has shown that coding specificity directly impacts the reliability of case identification in clinical databases (Theodosakis et al., 2022, JEADV).
ICD 10 Code for Other Melanin Hyperpigmentation
L81.4 covers "Other melanin hyperpigmentation" - a category that captures melanin-driven darkening that doesn't fit neatly into more specific classifications like melasma or post-inflammatory hyperpigmentation. This is one of the most frequently used hyperpigmentation codes because it covers a wide middle ground.
Melanin hyperpigmentation occurs when melanocytes - the pigment-producing cells in your skin - produce excess melanin in response to various stimuli. This excess melanin deposits in the epidermis, dermis, or both, creating visible darkening that can range from light brown to deep blue-black depending on the depth of pigment deposition.
Common presentations coded under L81.4 include solar lentigines (sun spots), diffuse hyperpigmentation without clear inflammatory trigger, and pigmentation changes that don't meet criteria for more specific diagnoses. If your provider documented hyperpigmentation but the cause isn't clearly inflammatory, hormonal, or drug-related, L81.4 is often the most appropriate classification.
This code is particularly relevant for patients with Fitzpatrick skin types IV through VI, where melanin reactivity is naturally higher and pigmentation changes can occur with minimal provocation. The burden of melanin-based hyperpigmentation varies significantly across skin tones and ethnicities, with documented disparities in both prevalence and quality-of-life impact (Sharma et al., 2024).
Post-Inflammatory Hyperpigmentation ICD 10 Code
L81.0 is the ICD-10 code for post-inflammatory hyperpigmentation (PIH). This is arguably the most relevant code for anyone reading this article after a cosmetic procedure, because PIH is the medical term for darkening that occurs after skin injury or inflammation.
Post-inflammatory hyperpigmentation happens when controlled or uncontrolled skin trauma triggers an inflammatory cascade that stimulates melanocytes to overproduce pigment. The key word here is "post-inflammatory" - meaning the darkening follows an identifiable inflammatory event.
That event could be:
→ A cosmetic procedure (microneedling, chemical peel, laser resurfacing)
→ Acne breakouts
→ Eczema or dermatitis flares
→ Burns or abrasions
→ Insect bites or skin infections
If you've recently had microneedling or a chemical peel and noticed dark patches developing in treated areas, this is likely the code that best describes what you're experiencing. PIH is typically temporary - resolving over weeks to months with proper aftercare - but the timeline varies significantly based on skin tone, depth of injury, and post-care compliance.
The good news: PIH is one of the most treatable and self-resolving forms of hyperpigmentation. The not-so-good news: it requires patience, consistent sun protection, and restraint from aggressive treatment of the darkened areas while healing is still in progress.
ICD 10 Code for Acne and Post-Acne Hyperpigmentation
Post-acne hyperpigmentation is a specific subtype of PIH where the inflammatory trigger is acne. The coding approach typically uses L81.0 (post-inflammatory hyperpigmentation) as the primary pigmentation code, often documented alongside the acne diagnosis code (L70.x series) to establish the causal relationship.
This dual-coding approach matters for treatment authorization. When insurance companies see both an acne code and a PIH code documented together, it establishes medical necessity for pigmentation-targeted treatments that might otherwise be classified as purely cosmetic.
Post-acne hyperpigmentation is extremely common in patients with darker skin tones. In many cases, the dark marks left behind by acne cause more distress than the active breakouts themselves. These marks represent melanin deposits triggered by the inflammatory acne lesion, and they can persist for months to years without intervention.
For coding purposes, the distinction matters: active acne with concurrent darkening is coded differently than resolved acne with residual pigmentation. Your provider should document whether active inflammatory acne is present or whether only post-inflammatory pigment changes remain, as this affects treatment planning and coverage decisions.
ICD 10 Code for Post-Burn Hyperpigmentation
Hyperpigmentation following burn injury is coded using L81.0 for the pigmentation component, typically in conjunction with the appropriate burn sequelae code from the T20-T32 category. The additional code T95.x (sequelae of burns) may be used to establish that the hyperpigmentation is a late effect of thermal injury.
Post-burn hyperpigmentation develops because thermal injury triggers intense inflammation and melanocyte stimulation during the healing process. The severity and permanence of post-burn pigmentation changes depend on burn depth, location, skin tone, and the quality of wound care during initial healing.
This coding scenario is relevant for patients who experienced burns from cosmetic procedures - including laser treatments that caused unexpected thermal injury, chemical peels that penetrated deeper than intended, or device-based treatments that overheated the skin. If your post-procedure hyperpigmentation resulted from a thermal or chemical burn rather than the intended controlled injury, your documentation should reflect this distinction.
Patients with post-burn hyperpigmentation may have stronger insurance coverage arguments for treatment because the condition results from injury rather than a purely cosmetic concern. Accurate coding that links the pigmentation to the burn event supports this documentation pathway.
ICD 10 Code for Post-Infection Hyperpigmentation
When hyperpigmentation develops following a skin infection - whether bacterial, viral, or fungal - it's coded as L81.0 (post-inflammatory hyperpigmentation) with an additional code documenting the preceding infection or its sequelae. Common scenarios include darkening after impetigo, herpes zoster (shingles), tinea infections, or cellulitis.
The inflammatory response triggered by infection can be intense, particularly in cases of deep or prolonged infections. This inflammation stimulates melanocytes in the affected area, leading to post-resolution darkening that may take weeks to months to fade.
For documentation purposes, timing matters. If the infection is still active, the infection code takes primary position. Once the infection resolves and only pigmentation remains, the PIH code may become the primary documented concern for follow-up visits focused on addressing the residual darkening.
Post-infection hyperpigmentation responds well to time, sun protection, and gentle depigmenting approaches once the skin has fully healed from the underlying infection. Aggressive treatment of the pigmentation before complete infection resolution can worsen both conditions.
ICD 10 Code for Drug-Induced Hyperpigmentation
Drug-induced hyperpigmentation uses code L81.8 (other specified disorders of pigmentation) along with additional coding to identify the responsible medication using the appropriate T36-T50 adverse effect codes. This dual-coding approach establishes the causal link between medication exposure and pigmentation change.
Research has specifically validated ICD-based case identification for hyperpigmentation in the setting of medication use. This means that when providers code drug-induced hyperpigmentation correctly, researchers can reliably identify these cases in large datasets - contributing to better understanding of medication side effect profiles (Theodosakis et al., 2022, JEADV).
Common medication classes associated with hyperpigmentation include tetracycline antibiotics (particularly minocycline), antimalarials (hydroxychloroquine), chemotherapy agents, certain antipsychotics, amiodarone, and heavy metals. The pattern and color of pigmentation often varies by causative medication - blue-gray for minocycline, yellow-brown for antimalarials, and diffuse darkening with chemotherapy.
If you suspect your medication is causing skin darkening, documentation is critical.
Consider tracking:
→ When the darkening first appeared relative to starting the medication
→ Which areas are affected
→ Whether the darkening is progressing or stable
→ Any photos documenting the timeline
This information helps your provider code accurately and supports decisions about medication alternatives.
ICD 10 Code for Minocycline-Induced Hyperpigmentation
Minocycline-induced hyperpigmentation represents one of the best-characterized drug-induced pigmentation syndromes. It's coded using L81.8 with the additional adverse effect code for tetracycline antibiotics (T36.4X5A for initial encounter). Three distinct clinical patterns are recognized.
Type I presents as blue-black discoloration in areas of prior scarring or inflammation - often in acne scars on the face. Type II appears as blue-gray pigmentation on the shins, forearms, or other sun-exposed areas. Type III causes diffuse muddy-brown discoloration that may also affect the nails and sclera.
The irony is not lost on dermatologists or patients: minocycline is commonly prescribed for acne, and the resulting hyperpigmentation can be cosmetically more distressing than the acne it was meant to treat. This is particularly problematic for patients with darker skin tones who may already be managing post-acne PIH.
The good news is that minocycline-induced hyperpigmentation often improves after medication discontinuation, though resolution can take months to years depending on the type and duration of exposure. Laser treatments, particularly Q-switched lasers, have shown efficacy for resistant cases.
ICD 10 Code for Hyperpigmentation Due to Radiation
Radiation-induced hyperpigmentation is coded under L57.8 (other skin changes due to chronic exposure to nonionizing radiation) or using the appropriate radiation sequelae codes from L59 (other disorders of skin and subcutaneous tissue related to radiation). The specific code depends on whether the radiation was therapeutic (such as cancer treatment) or from another source.
Radiation therapy commonly causes hyperpigmentation within the treatment field. This "radiation dermatitis" progresses through stages - initial erythema, followed by darkening, possible desquamation, and eventual chronic pigmentation changes in some patients.
For patients experiencing post-radiation hyperpigmentation, the coding establishes the condition as a medical consequence of necessary treatment rather than a cosmetic concern. This distinction is important for insurance coverage of subsequent dermatological care aimed at managing the pigmentation changes.
UV radiation from sun exposure represents another mechanism of radiation-induced hyperpigmentation, though this is typically coded under the solar lentigo or melanin hyperpigmentation categories rather than the radiation-specific codes reserved for therapeutic radiation exposure.
ICD 10 Code for Hyperpigmentation in Pregnancy
Pregnancy-related hyperpigmentation - commonly manifesting as melasma (the "mask of pregnancy"), linea nigra, or darkening of the areolae and genital skin - is typically coded using L81.1 (chloasma/melasma) when facial, or O99.7 (diseases of the skin and subcutaneous tissue complicating pregnancy) for pregnancy-specific documentation.
Hormonal fluctuations during pregnancy, particularly elevated estrogen and progesterone, stimulate melanocyte activity throughout the body. While some degree of skin darkening is nearly universal in pregnancy, clinically significant melasma affects a substantial proportion of pregnant individuals, with higher prevalence in darker skin tones.
The coding considerations during pregnancy are unique because many standard treatments for hyperpigmentation (hydroquinone, retinoids, certain laser modalities) are contraindicated during pregnancy and lactation. Documentation should clearly link the pigmentation to pregnancy to guide appropriate treatment timing - typically deferred until after delivery and breastfeeding completion.
Post-partum, some pregnancy-related hyperpigmentation resolves spontaneously as hormonal levels normalize. Persistent melasma may require active treatment and is then coded under the standard melasma classification without pregnancy modification.
ICD 10 Code for Newborn Hyperpigmentation
Hyperpigmentation in newborns is coded within the P83 category (other conditions of integument specific to newborn) or using the congenital pigmentation codes from Q82.8 (other specified congenital malformations of skin). The specific selection depends on whether the pigmentation is considered a normal variant, a transient neonatal finding, or a congenital anomaly requiring monitoring.
Common neonatal pigmentation findings include Mongolian spots (dermal melanocytosis, coded Q82.8), café-au-lait macules, and physiologic darkening of the genitalia and linea alba. Most are benign variants that require no intervention beyond documentation and parental education.
However, certain neonatal pigmentation patterns warrant further evaluation. Multiple café-au-lait spots may suggest neurofibromatosis. Extensive dermal melanocytosis may overlap with phakomatosis pigmentovascularis. Accurate initial coding supports appropriate follow-up and monitoring as the child grows.
For pediatric providers, the distinction between physiologic neonatal pigmentation and pathologic findings drives coding decisions. Parents should be reassured that most neonatal pigmentation variants are benign while understanding that documentation supports ongoing developmental monitoring.
ICD 10 Code for Facial Hyperpigmentation
Facial hyperpigmentation is among the most commonly coded pigmentation concerns due to its cosmetic visibility and psychosocial impact. The primary codes used include L81.1 (melasma/chloasma) for hormonally-driven facial pigmentation, L81.0 for post-inflammatory facial darkening, and L81.4 for other melanin-based facial hyperpigmentation.
The face presents unique coding challenges because multiple hyperpigmentation subtypes commonly co-occur. A single patient might have melasma on the cheeks, post-acne PIH on the chin, and solar lentigines on the forehead - each technically warranting different coding. In practice, providers typically code the primary or most clinically significant pattern.
For treatment authorization purposes, facial hyperpigmentation often receives more favorable insurance consideration than body pigmentation because of documented quality-of-life impacts. Studies on melasma specifically have quantified the psychosocial burden and demonstrated that the condition significantly affects patients' daily functioning and emotional wellbeing (Sharma et al., 2024).
Documentation specificity for facial hyperpigmentation should include distribution pattern (centrofacial, malar, mandibular), suspected etiology, and any triggering factors like recent procedures, sun exposure, or hormonal changes.
ICD 10 Code for Mottled Facial Hyperpigmentation
Mottled facial hyperpigmentation - characterized by irregular, patchy pigmentation with mixed areas of darkening and relative lightening - is typically coded under L81.4 (other melanin hyperpigmentation) or L81.8 (other specified disorders of pigmentation) depending on the suspected underlying cause.
This presentation is distinct from the more uniform pigmentation seen in classical melasma. Mottled patterns often suggest photodamage, poikiloderma, or mixed pigmentation disorders where both hyperpigmentation and hypopigmentation coexist. The clinical appearance can also result from partial treatment response - where some areas lighten with therapy while others remain dark.
Poikiloderma of Civatte, a specific entity featuring mottled pigmentation with telangiectasia on the neck and lateral face, has its own clinical recognition but is still coded within the L81 category. The mottled pattern often requires different treatment approaches than uniform hyperpigmentation, making accurate coding and documentation of the pattern clinically relevant.
For post-procedure patients, mottled pigmentation may indicate uneven treatment depth, variable healing response, or contact with irritants during recovery. Document the pattern, distribution, and any correlation with treatment zones to guide both coding and treatment planning.
ICD 10 Code for Periorbital and Infraorbital Hyperpigmentation
Periorbital hyperpigmentation - commonly known as "dark circles" - is coded under L81.4 (other melanin hyperpigmentation) with location-specific documentation. When associated with dermatitis, it may additionally be coded under the appropriate eczema category, as allergic or atopic dermatitis is a common contributing factor to infraorbital darkening.
The periorbital area presents unique pathophysiology compared to other facial zones. Thin skin allows underlying vasculature to show through (vascular component), dermal melanin deposition creates true hyperpigmentation, and shadowing from anatomical hollowing creates an optical illusion of darkening. Treatment and coding should ideally address the predominant mechanism.
True melanin-based periorbital hyperpigmentation responds to depigmenting agents and gentle chemical peels. Vascular dark circles respond better to vascular-targeted treatments. Shadowing responds to volume restoration. Accurate clinical assessment drives appropriate coding - and appropriate coding drives appropriate treatment authorization.
This area is particularly sensitive to post-procedure PIH due to the thin, vascular skin. Patients undergoing periorbital treatments should receive specific counseling about PIH risk and the importance of gentle aftercare in this delicate zone.
ICD 10 Code for Perioral and Lip Hyperpigmentation
Perioral hyperpigmentation is coded under L81.4 or L81.8, while lip pigmentation may fall under K13.7 (other and unspecified lesions of oral mucosa) when involving the vermilion border or labial mucosa. The distinction between skin and mucosal involvement is clinically significant.
Common causes of perioral hyperpigmentation include hormonal influences (melasma often affects the mandibular region), contact dermatitis from lip products, post-inflammatory changes from perioral dermatitis, and chronic lip-licking habits. Each cause has different treatment implications and prognostic expectations.
⚠️ Important clinical note: Mucocutaneous lip pigmentation - particularly multiple discrete pigmented macules on the lips and oral mucosa - can be associated with Peutz-Jeghers syndrome, a genetic condition requiring medical evaluation and surveillance (Tong et al., 2023). If you have unexplained pigmented spots on your lips or inside your mouth that are not related to any procedure or product, mention this to your provider for appropriate evaluation.
For cosmetic pigmentation concerns limited to the perioral skin, gentle depigmenting approaches and sun protection form the foundation of treatment, with coding supporting coverage when the condition is documented as a medical pigmentation disorder rather than a purely aesthetic preference.
ICD 10 Code for Neck Hyperpigmentation
Neck hyperpigmentation is coded under L81.4 or L81.8 with anatomical location documentation. The neck is a common site for several distinct pigmentation patterns, each with different clinical implications and coding nuances.
Acanthosis nigricans of the neck - velvety, dark thickening - uses code L83 rather than the L81 hyperpigmentation codes, as it represents a distinct pathological process often associated with insulin resistance. This distinction is clinically important: what appears to be "just darkening" on the neck may indicate metabolic disease requiring systemic evaluation.
True hyperpigmentation of the neck may result from friction (necklaces, clothing), sun exposure (posterior neck), post-inflammatory changes from contact dermatitis, or extension of facial melasma. Poikiloderma of Civatte specifically affects the lateral neck with a characteristic mottled pattern sparing the submental shadow.
For patients presenting with neck darkening, providers should differentiate between true hyperpigmentation (melanin excess), acanthosis nigricans (epidermal thickening), and dermatitis-related changes, as the coding - and the treatment implications - differ significantly for each.
ICD 10 Code for Axillary Hyperpigmentation
Axillary (underarm) hyperpigmentation is coded under L81.4 with site documentation, unless the presentation suggests acanthosis nigricans (L83) or post-inflammatory changes from contact dermatitis or folliculitis (L81.0). The axillary region is prone to pigmentation changes due to friction, shaving trauma, deodorant sensitivity, and hormonal influences.
Friction-related axillary darkening is among the most common pigmentation complaints in clinical practice, particularly among patients with darker skin tones. The repetitive mechanical irritation from arm movement, tight clothing, and shaving stimulates melanocyte activity in this already melanin-rich area.
Treatment approaches for axillary hyperpigmentation focus on reducing friction (switching to loose clothing, laser hair removal instead of shaving), addressing any underlying dermatitis, and gentle depigmenting protocols. More aggressive treatments carry PIH risk in this sensitive, occluded area.
Coding accuracy matters here because insurers may classify axillary treatments as cosmetic. When the hyperpigmentation is clearly linked to dermatitis, folliculitis, or acanthosis nigricans (with metabolic workup), medical necessity is more easily established.
ICD 10 Code for Breast Hyperpigmentation
Breast hyperpigmentation is coded under L81.4 or L81.0 depending on etiology, with site-specific documentation. Physiologic darkening of the areolae during pregnancy is normal and typically not coded as pathology. Pathologic breast hyperpigmentation may result from post-inflammatory changes, radiation therapy, friction, or inflammatory breast conditions.
Post-radiation hyperpigmentation of the breast is particularly common following breast cancer treatment. These patients may develop persistent darkening within the radiation field that can be distressing and may benefit from dermatologic intervention. Coding should link the pigmentation to radiation sequelae for appropriate treatment authorization.
Inframammary hyperpigmentation from chronic friction and moisture (intertrigo-related) is another common presentation, particularly in patients with larger breast size. This requires addressing the underlying mechanical and moisture factors alongside any pigmentation treatment.
For cosmetic procedures on the chest - such as laser treatments or chemical peels for décolletage rejuvenation - resulting PIH uses standard L81.0 coding with documentation of the triggering procedure.
ICD 10 Code for Vulvar Hyperpigmentation
Vulvar hyperpigmentation is coded under L81.4 with genital site documentation, or may use N90.89 (other specified noninflammatory disorders of vulva and perineum) depending on clinical context. It's important to distinguish physiologic vulvar pigmentation - which is normal and varies with skin tone, age, and hormonal status - from pathologic darkening requiring evaluation.
Pathologic vulvar hyperpigmentation may result from chronic lichen simplex chronicus, post-inflammatory changes from vulvar dermatitis, friction, or hormonal influences. In some cases, new or changing pigmentation in the vulvar area requires biopsy to rule out melanosis or melanoma.
Providers coding vulvar pigmentation should document whether the pigmentation is new, changing, symptomatic, or associated with other vulvar findings. This specificity guides appropriate follow-up and ensures that pigmentation warranting further evaluation is not dismissed as purely cosmetic.
Patients concerned about vulvar darkening should be reassured that normal vulvar pigmentation varies widely and often darkens with age and hormonal exposure. However, new, asymmetric, or rapidly changing pigmentation merits clinical evaluation.
ICD 10 Code for Hand Hyperpigmentation
Hand hyperpigmentation is coded under L81.4 with upper extremity site documentation. The hands are among the most common sites for solar lentigines (age spots/sun spots) due to chronic cumulative UV exposure. Post-inflammatory darkening from eczema, contact dermatitis, or burns is coded under L81.0.
The dorsal hands receive substantial sun exposure throughout life and have relatively thin skin, making them vulnerable to photodamage-related pigmentation. This is a common cosmetic concern that drives patients to seek treatment - but the coding determines whether insurance participates in management.
When hand hyperpigmentation results from documented dermatitis, occupational exposure, or clearly identified inflammatory conditions, medical necessity coding is straightforward. When it represents cumulative photodamage without an inflammatory component, it's more challenging to establish medical necessity beyond cosmetic indication.
Treatment of hand hyperpigmentation requires particular attention to aftercare, as the hands are difficult to protect from sun exposure and mechanical irritation during daily activities. Any post-procedure PIH risk on the hands is compounded by these practical challenges.
ICD 10 Code for Leg and Lower Extremity Hyperpigmentation
Lower extremity hyperpigmentation uses L81.4 for general melanin hyperpigmentation with site documentation, L81.0 for post-inflammatory presentations, or specific codes when related to venous insufficiency (I87.2 - venous insufficiency) or hemosiderin deposition associated with chronic venous disease.
The legs present unique pigmentation challenges. Venous stasis hyperpigmentation - reddish-brown discoloration of the lower legs from chronic venous insufficiency - represents hemosiderin deposition rather than melanin excess and requires different coding and treatment approaches than melanin-based hyperpigmentation.
Post-inflammatory hyperpigmentation on the legs commonly follows insect bites, razor bumps (pseudofolliculitis), folliculitis, and shaving trauma. These marks can persist longer on the lower extremities due to slower skin turnover and gravitational blood flow patterns.
For accurate coding, providers should distinguish between melanin-based hyperpigmentation, hemosiderin staining from venous disease, and post-inflammatory changes from identified triggers. Each carries different treatment implications and insurance considerations.
ICD 10 Code for Foot Hyperpigmentation
Foot hyperpigmentation is coded under L81.4 with lower extremity site documentation. Specific considerations for the feet include plantar melanosis (pigmented macules on the soles), post-inflammatory changes from tinea pedis or contact dermatitis, and hyperpigmentation from chronic friction or pressure.
Plantar pigmentation requires careful clinical evaluation because melanoma of the acral surfaces (including soles of feet) has unique epidemiologic patterns and can initially present as benign-appearing hyperpigmentation. Any new, changing, or asymmetric pigmented lesion on the sole should undergo dermoscopic evaluation and possible biopsy.
For non-concerning foot hyperpigmentation - such as PIH from resolved athlete's foot, friction darkening from ill-fitting shoes, or medication-related pigmentation - standard hyperpigmentation coding applies. Documentation should note whether the presentation has been evaluated and cleared as benign.
ICD 10 Code for Venous Stasis Hyperpigmentation
Venous stasis hyperpigmentation represents hemosiderin deposition from chronic venous insufficiency rather than true melanin hyperpigmentation. It's primarily coded using I87.2 (venous insufficiency, chronic/peripheral) along with L81.8 or the appropriate skin change codes. The specific coding approach reflects that this is a vascular condition manifesting as skin discoloration.
The pathophysiology differs fundamentally from melanin-based hyperpigmentation: elevated venous pressure causes red blood cell extravasation into surrounding tissue, where hemoglobin breaks down into hemosiderin - an iron-containing brown pigment. The characteristic reddish-brown discoloration of the gaiter area (lower legs above the ankles) is the classic presentation.
Treatment focuses on addressing the underlying venous insufficiency through compression therapy, elevation, exercise, and sometimes surgical intervention - rather than topical depigmenting agents, which are ineffective against hemosiderin deposits.
Coding venous stasis changes under vascular rather than dermatologic primary codes supports appropriate referral patterns and treatment authorization. Patients should understand that this type of leg darkening requires different management than melanin-based post-inflammatory hyperpigmentation.
ICD 10 Code for Nail and Toenail Hyperpigmentation
Nail hyperpigmentation - melanonychia - is coded under L60.8 (other nail disorders) or L81.8 when documentation emphasizes the pigmentation aspect. The coding depends on whether the presentation is approached as a nail disorder or a pigmentation disorder.
Melanonychia presents as a longitudinal brown or black streak in the nail plate. It's extremely common as a normal variant in patients with darker skin tones - up to 77% of African Americans may have some degree of nail pigmentation. However, it can also represent nail matrix melanoma (subungual melanoma), making clinical evaluation essential.
Key features requiring urgent evaluation: a single digit affected, widening of the pigmented band over time, nail plate destruction, pigment extending onto the proximal or lateral nail fold (Hutchinson sign), or new-onset melanonychia in a patient without prior nail pigmentation.
Drug-induced nail pigmentation - from chemotherapy, antimalarials, or minocycline - is coded with both the nail disorder and adverse medication effect codes. Documentation should note the pattern, number of nails affected, and any associated medication exposure.
ICD 10 Code for Oral and Tongue Hyperpigmentation
Oral mucosal hyperpigmentation is coded under K13.7 (other and unspecified lesions of oral mucosa) rather than the skin-specific L81 codes. Tongue pigmentation may use K14.8 (other diseases of tongue). The mucosal location drives the use of digestive system codes rather than integumentary codes.
Oral pigmentation has numerous causes: racial/physiologic pigmentation (extremely common in darker skin tones), smoker's melanosis, medication-induced changes (particularly from antimalarials, minocycline, and chemotherapy), amalgam tattoos from dental work, and systemic conditions.
⚠️ When to seek evaluation: Multiple pigmented macules on the lips and oral mucosa - particularly in a younger patient - may be associated with Peutz-Jeghers syndrome, a hereditary condition requiring gastrointestinal surveillance. Case reports document the association between mucocutaneous pigmentation and internal malignancy in this syndrome (Tong et al., 2023). If you have unexplained oral pigmentation along with any gastrointestinal symptoms or family history of polyps, discuss this with your provider.
Most oral pigmentation is benign, but new, rapidly expanding, or asymmetric mucosal pigmentation warrants biopsy to rule out mucosal melanoma, which carries a worse prognosis than cutaneous melanoma due to typically delayed diagnosis.
ICD 10 Code for Eye and Eyelid Hyperpigmentation
Eyelid skin hyperpigmentation uses L81.4 with periorbital location documentation. Conjunctival pigmentation uses H11.0x codes (pterygium) or H11.30 (conjunctival deposits) depending on the specific presentation. The distinction between eyelid skin, conjunctival, scleral, and retinal pigmentation is critical for appropriate coding.
Eyelid hyperpigmentation overlaps significantly with periorbital dark circles discussed earlier. True eyelid skin pigmentation may result from chronic rubbing (allergic conjunctivitis leading to repeated eye rubbing), atopic dermatitis of the eyelid skin, contact allergy to eye cosmetics, or medication effects.
The thin, delicate nature of eyelid skin makes this area particularly susceptible to post-inflammatory darkening and simultaneously makes treatment challenging. Aggressive interventions carry significant PIH risk in this zone, and many standard depigmenting agents cause irritation when applied near the eyes.
Documentation should distinguish between the eyelid skin (integumentary coding), conjunctival surface (anterior segment ophthalmology coding), and periocular soft tissue. Each anatomical subsite has different coding pathways and referral implications.
ICD 10 Code for Scleral Hyperpigmentation
Scleral pigmentation - darkening or discoloration of the white of the eye - is coded using ophthalmology-specific codes rather than dermatologic pigmentation codes. H15.89 (other disorders of sclera) is commonly used, with additional coding for the underlying cause when identified.
Scleral pigmentation can be physiologic (melanin deposits common in darker skin tones), medication-induced (minocycline, particularly Type III pattern), metabolic (ochronosis in alkaptonuria), or post-inflammatory. The clinical significance varies dramatically depending on etiology.
Racial melanosis of the sclera - flat, patchy brown pigmentation - is a normal variant requiring no treatment. In contrast, progressive scleral darkening in a patient on tetracycline antibiotics suggests medication toxicity requiring drug discontinuation. Blue-gray scleral pigmentation may indicate ochronosis - a systemic condition requiring metabolic evaluation.
Patients noticing new scleral discoloration should be evaluated by an ophthalmologist who can distinguish between benign variants, medication effects, and conditions requiring systemic workup. Coding should reflect the specific etiology once determined.
ICD 10 Code for Retinal and RPE Hyperpigmentation
Retinal and retinal pigment epithelium (RPE) hyperpigmentation uses ophthalmology codes from H35.89 (other specified retinal disorders) or specific codes for conditions like congenital hypertrophy of the RPE (CHRPE). These are entirely separate from skin hyperpigmentation codes and represent fundoscopic findings documented during eye examinations.
RPE hyperpigmentation may be an incidental finding on routine eye examination, a marker of retinal disease progression, or - in the case of grouped pigmentation (bear track pigmentation) - a benign congenital variant. Multiple CHRPE lesions may be associated with familial adenomatous polyposis (Gardner syndrome variant), similar to how mucocutaneous pigmentation can signal Peutz-Jeghers syndrome in the gastrointestinal context.
For dermatology patients: retinal findings are outside the scope of skin pigmentation management but may be relevant when systemic conditions (medication toxicity, metabolic disease) affect both skin and ocular pigmentation simultaneously. Minocycline, for example, can cause both skin and scleral pigmentation.
Coding for retinal findings is managed by ophthalmology and is documented separately from any concurrent skin pigmentation coding.
ICD 10 Code for Acquired Dermal Macular Hyperpigmentation
Acquired dermal macular hyperpigmentation (also known as idiopathic dermal melanocytosis or acquired bilateral nevus of Ota-like macules/Hori nevus) is coded under L81.4 (other melanin hyperpigmentation) or Q82.8 when the clinical determination leans toward a developmental melanocytic condition. The distinction depends on timing of onset and clinical classification.
This condition presents as bilateral blue-gray to brown macules, typically on the malar cheeks, temples, forehead, or nasal bridge. It's most commonly seen in Asian populations and is often confused with melasma - but the treatment approach differs significantly because the pigment resides in the dermis rather than the epidermis.
The dermal location of pigment means that topical depigmenting agents have limited efficacy. Treatments targeting dermal melanocytes - such as Q-switched lasers or picosecond lasers - are typically required. Accurate diagnosis (and therefore accurate coding) is crucial because treating this condition as melasma leads to treatment failure and patient frustration.
Coding this condition specifically - rather than using a generic melasma or unspecified hyperpigmentation code - supports appropriate treatment selection and authorization for laser-based interventions that insurance may not cover under a standard "melasma" diagnosis.
ICD 10 Code for Linear and Diffuse Hyperpigmentation
Linear hyperpigmentation is coded under L81.8 (other specified disorders of pigmentation) with documentation of the linear pattern. Diffuse hyperpigmentation uses the same code or L81.4 depending on the clinical context and suspected cause. Pattern documentation is essential for these presentations because the morphology often suggests specific etiologies.
Linear hyperpigmentation patterns may indicate:
→ Phytophotodermatitis (linear streaks from plant sap plus sun exposure)
→ Flagellate hyperpigmentation (from bleomycin or shiitake mushroom dermatitis)
→ Linear lichen planus (Blaschko lines distribution)
→ External contactant pattern (belt lines, bra straps, friction points)
Diffuse hyperpigmentation may suggest systemic causes including Addison disease, hemochromatosis, medication effects, or nutritional deficiencies. The pattern guides diagnostic workup - diffuse darkening often warrants bloodwork to rule out endocrine or metabolic disease.
For coding purposes, documenting the specific pattern (linear, reticular, diffuse, flagellate) in clinical notes supports appropriate ICD code selection and justifies any systemic workup ordered based on the pigmentation pattern.
ICD 10 Code for Hyperpigmented Skin Lesions and Scars
Hyperpigmented scars are coded using L90.5 (scar conditions and fibrosis of skin) as the primary code, with L81.0 (post-inflammatory hyperpigmentation) as an additional code to document the pigmentation component. This dual-coding approach captures both the structural scar and the pigmentary change.
Hypertrophic scars and keloids in patients with darker skin tones frequently develop hyperpigmentation that compounds their cosmetic and functional impact. The scar itself and its pigmentation may require different treatment approaches - the scar may need intralesional steroids or silicone therapy, while the pigmentation benefits from sun protection and depigmenting agents.
Post-surgical hyperpigmentation - darkening along incision lines or around healing wounds - is a common concern that responds well to time and photoprotection. Documentation should link the pigmentation to the surgical site for accurate coding.
For patients with post-procedure scars that developed hyperpigmentation - such as darkened areas around microneedling sites that were treated too aggressively or laser-treated areas that scarred - combined scar and pigmentation coding supports comprehensive treatment authorization.
How to Choose the Correct Hyperpigmentation ICD 10 Code
Selecting the most appropriate hyperpigmentation ICD-10 code follows a clinical decision pathway that considers etiology, anatomical location, temporal relationship to triggering events, and the level of diagnostic certainty available at the time of coding. Here's a simplified framework for understanding how providers navigate this decision:
Step 1 → Identify the cause. Is the hyperpigmentation post-inflammatory (following a known trigger), hormonal (pregnancy, birth control), drug-induced (medication exposure), or idiopathic (no clear cause)?
Step 2 → Note the location. Facial, perioral, periorbital, extremity, mucosal, or widespread? Location may shift coding away from L81 toward organ-specific codes (eye, oral mucosa).
Step 3 → Determine the depth. Epidermal pigment (brown, well-defined borders) versus dermal pigment (gray-blue, diffuse edges) may influence code selection and treatment planning.
Step 4 → Document specificity. The more information available, the more specific the code should be. "Post-inflammatory hyperpigmentation following microneedling, bilateral cheeks" enables more precise coding than "dark spots on face."
Step 5 → Consider dual coding. When hyperpigmentation exists alongside the condition that caused it (active acne plus PIH, venous insufficiency plus stasis changes), both should be documented.
Research validates that this specificity matters at scale. ICD-based case identification for hyperpigmentation and melasma has been formally validated in large healthcare datasets - meaning that when providers code accurately, these codes reliably identify true cases for research purposes (Theodosakis et al., 2022, JEADV; Theodosakis et al., 2022, JAMA Dermatol). Better individual coding contributes to better population-level understanding of hyperpigmentation conditions.
For patients, the actionable takeaway is this: help your provider help you. Mention the trigger, the timeline, the location, and any medications you're taking. This information enables the most specific, accurate coding - which supports your insurance claims, your treatment plan, and the broader research that will improve hyperpigmentation management for everyone.
Post-Procedure Hyperpigmentation: What's Normal and What Helps
If you're reading this article because you developed dark spots after microneedling, a chemical peel, or laser treatment - take a breath. Post-inflammatory hyperpigmentation following cosmetic procedures is common, typically temporary, and manageable with appropriate aftercare.
Here's what you need to know: cosmetic procedures like microneedling and chemical peels work by creating controlled injury to trigger your skin's repair mechanisms. That controlled injury involves inflammation - and inflammation can stimulate melanocytes. The result is PIH, coded as L81.0, and it's a recognized potential outcome rather than a sign that something went terribly wrong.
Risk factors for developing post-procedure PIH include:
→ Darker skin tones (Fitzpatrick IV-VI) - higher melanocyte reactivity
→ History of PIH from previous procedures or skin injuries
→ Inadequate sun protection during recovery
→ Active inflammation at time of procedure
→ Aggressive treatment parameters not appropriate for your skin type
→ Premature use of active ingredients during healing
Recovery Timeline Framework
📅 Days 0-1: Redness, warmth, mild swelling. Skin barrier is open. Apply only gentle cleanser and recovery products as directed. No makeup, no actives, no sun exposure.
📅 Days 2-3: Tightness, possible flaking or dryness. Continue hydration and barrier support. If using exosome-based recovery products, this is the window where delivery is optimized through the still-permeable barrier.
📅 Days 4-7: Skin surface normalizing. Mild darkening may appear in treated areas - this is not necessarily permanent PIH but part of the inflammatory healing cycle. Continue sun protection and gentle care.
📅 Weeks 2-4: Any true PIH should begin to stabilize. Active darkening should stop. If pigmentation is worsening beyond week 2, contact your provider.
📅 Weeks 4-12: Resolution window. Most procedure-related PIH begins fading during this period with consistent sun protection and patience. Gentle brightening ingredients may be introduced only when cleared by your provider.
Post-Procedure Do's and Don'ts
✓ Apply broad-spectrum SPF 30+ daily - reapply every 2 hours outdoors
✓ Keep treated skin hydrated with fragrance-free moisturizer
✓ Follow your provider's specific aftercare protocol exactly
✓ Use recovery-focused products designed for post-procedure skin
✓ Document changes with photos and dates
✓ Contact your provider if darkening worsens beyond 2-3 weeks
✗ Do not use active acids (AHA, BHA, retinol) until cleared
✗ Do not pick, scratch, or manually exfoliate treated areas
✗ Do not expose healing skin to direct sun without protection
✗ Do not layer multiple new products simultaneously
✗ Do not assume darkening is permanent - PIH typically resolves
Where Exosomes Fit in Recovery
Exosome-based recovery serums represent an emerging category in post-procedure skincare. Exosomes are cell-derived signaling vesicles that participate in intercellular communication, and in the recovery context, they're designed to support your skin's natural repair signaling during the critical post-procedure healing window.
The rationale is straightforward: after microneedling or laser, your skin's barrier is intentionally disrupted and your cells are actively communicating repair signals. Recovery products containing exosomes aim to support this signaling cascade - calming inflammation and supporting barrier restoration during the window when skin is most receptive.
This is complementary to - not a replacement for - sun protection, hydration, and time. No recovery product eliminates the need for patience and photoprotection. But supporting the healing process from day one may help create conditions less favorable for persistent PIH development.
When to See Your Provider About Hyperpigmentation
Most post-procedure hyperpigmentation resolves with time and proper care. However, certain presentations warrant prompt medical evaluation:
→ Pigmentation worsening progressively beyond 3-4 weeks post-procedure
→ Pain, warmth, or pustules associated with darkened areas (possible infection)
→ Pigmentation spreading well beyond the treated zone
→ New pigmented lesions with irregular borders, multiple colors, or rapid growth
→ Mucosal pigmentation (lips, gums, tongue) without clear cause
→ Systemic symptoms alongside skin darkening (fatigue, GI issues, weight changes)
The burden of hyperpigmentation - particularly melasma - extends beyond cosmetic concern. Published research documents significant quality-of-life impacts, associations with comorbidities, and disparities in burden across race and ethnicity that underscore the importance of taking these conditions seriously in clinical settings (Sharma et al., 2024).
ICD Codes in Research and Digital Health
Understanding why coding accuracy matters extends beyond your individual visit. Validated ICD coding allows researchers to study hyperpigmentation populations at scale - identifying patterns, treatment gaps, and health disparities that inform better future care.
The validation work by Theodosakis and colleagues established that ICD-10 codes can reliably identify true cases of both general hyperpigmentation (in medication-use settings) and melasma specifically in large healthcare databases (Theodosakis et al., 2022, JEADV; Theodosakis et al., 2022, JAMA Dermatol). This methodological foundation enables population-level research into prevalence, demographics, treatment patterns, and outcomes.
Parallel advances in digital health are exploring AI-based skin disease classification using methods like Grad-CAM (Gradient-weighted Class Activation Mapping) and transfer learning to identify skin conditions from images (Badhon et al., 2025). These approaches complement ICD coding by potentially enabling image-based classification that doesn't depend on provider documentation. Together, validated coding and AI classification represent complementary pathways toward better understanding and managing pigmentation disorders at scale.
For patients, the practical takeaway is this: every accurately coded visit contributes data that helps researchers understand who develops hyperpigmentation, under what circumstances, and how it responds to treatment. Your individual record, properly documented, becomes part of the evidence base that drives better care for future patients.
Frequently Asked Questions
What ICD-10 code is used for hyperpigmentation?
The most commonly used code is L81.4 for other melanin hyperpigmentation. Post-inflammatory hyperpigmentation uses L81.0, melasma uses L81.1, and unspecified pigmentation disorders use L81.9. Your provider selects the specific code based on the cause, location, and clinical presentation.
Is post-procedure hyperpigmentation permanent?
Post-inflammatory hyperpigmentation after procedures like microneedling or chemical peels is typically temporary, resolving over 4-12 weeks with proper sun protection and gentle aftercare. Darker skin tones may experience longer resolution timelines but the condition generally improves with patience and photoprotection.
Will insurance cover treatment for hyperpigmentation?
Coverage depends on your specific plan and how the condition is coded. Hyperpigmentation coded as a medical condition (post-inflammatory, drug-induced, or associated with a documented disease) has better coverage prospects than pigmentation documented as purely cosmetic. Ask your provider to code the specific cause and trigger.
What is the difference between L81.0 and L81.4?
L81.0 specifically identifies post-inflammatory hyperpigmentation - darkening that follows an identified inflammatory trigger like acne, a procedure, or dermatitis. L81.4 covers other melanin-based hyperpigmentation without a clear inflammatory origin, such as solar lentigines or diffuse pigmentation.
Can melasma be coded differently from regular hyperpigmentation?
Yes. Melasma has its own dedicated code, L81.1, and research has validated that this code reliably identifies true melasma cases in clinical databases. Using the melasma-specific code rather than generic hyperpigmentation coding supports more accurate treatment planning and research tracking.
Should I ask my doctor to change my hyperpigmentation ICD code?
You can request that your provider document the specific cause, trigger, and location of your hyperpigmentation to enable the most accurate coding possible. More specific documentation supports better coding, which can improve insurance authorization for targeted treatments.
What does unspecified hyperpigmentation mean on my chart?
L81.9 (unspecified disorder of pigmentation) means your provider documented a pigmentation concern without classifying it into a more specific category. This might occur at an initial visit before full evaluation. You can ask for more specific documentation at follow-up once the type and cause are better characterized.
Is hyperpigmentation after microneedling normal?
Mild, transient darkening in treated areas during the first 1-2 weeks is within the normal healing spectrum. True post-inflammatory hyperpigmentation developing beyond the immediate healing period is a recognized potential side effect, particularly for darker skin tones. Consistent sun protection during recovery significantly reduces this risk.
References
Theodosakis N, Yoon J, Young K, Getachew E, Mostaghimi A, Semenov Y. Validation of case identification for hyperpigmentation in the setting of medication use using international classification of diseases coding. J Eur Acad Dermatol Venereol. 2022;36(12):e1001-e1003. doi:10.1111/jdv.18402
Theodosakis N, Yoon J, Young K, Getachew E, Mostaghimi A, Semenov YR. Validation of Case Identification for Melasma Using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision Codes. JAMA Dermatol. 2022;158(12):1453-1454. doi:10.1001/jamadermatol.2022.3872
Sharma AN, Kincaid CM, Mesinkovska NA. The Burden of Melasma: Race, Ethnicity, and Comorbidities. J Drugs Dermatol. 2024;23(8):691-693. doi:10.36849/JDD.8233
Tong T, Fan Q, Shi S, Li Y, Wang Y. Gastric-type mucinous adenocarcinoma of the cervix in a woman with Peutz-Jeghers syndrome: a case report. Acta Chir Belg. 2023;123(4):448-453. doi:10.1080/00015458.2022.2040110
Badhon SMSI, Khushbu SA, Shaqib SM, Ali MA, Anik AH, Hossain KSMT. Explainable AI for skin disease classification using gradient-weighted class activation mapping and transfer learning in digital health to identify contours. Digit Health. 2025;11:20552076251404523. doi:10.1177/20552076251404523
